Marc R. Schneebaum
2019
In 2019, Marc R. Schneebaum earned a total compensation of $3.5M as Senior Vice President, Chief Financial Officer at Synta Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $223,298 |
|---|---|
| Option Awards | $2,868,320 |
| Salary | $421,000 |
| Other | $20,034 |
| Total | $3,532,652 |
Schneebaum received $2.9M in option awards, accounting for 81% of the total pay in 2019.
Schneebaum also received $223.3K in non-equity incentive plan, $421K in salary and $20K in other compensation.
Rankings
In 2019, Marc R. Schneebaum's compensation ranked 3,437th out of 13,971 executives tracked by ExecPay. In other words, Schneebaum earned more than 75.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,437 out of 13,971 | 75th |
Division Manufacturing | 1,246 out of 5,692 | 78th |
Major group Chemicals And Allied Products | 428 out of 2,189 | 80th |
Industry group Drugs | 356 out of 1,875 | 81st |
Industry Pharmaceutical Preparations | 268 out of 1,387 | 81st |
Pay ratio
| Marc R. Schneebaum's Pay | $3,532,652 |
|---|---|
| Median Employee's Pay | $791,000 |
| Pay Ratio | 4to 1 |
In 2019, the annual total compensation of Marc R. Schneebaum was $3,532,652.
The annual total compensation of the median employee at Synta Pharmaceuticals was $791,000.
The ratio of Marc R. Schneebaum's pay to the pay of median employee was therefore 4 to one.
Source: SEC filing on April 29, 2020.
Schneebaum's colleagues
We found four more compensation records of executives who worked with Marc R. Schneebaum at Synta Pharmaceuticals in 2019.